We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
TNFRSF14 / CD270 (N-Terminus) antibody
Tumor necrosis factor receptor superfamily member 14
Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA
Tumor necrosis factor receptor-like 2, TR2
CD_antigen: CD270
ATAR, LIGHTR
Gene name: TNFRSF14, HVEA, HVEM
Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA
Tumor necrosis factor receptor-like 2, TR2
CD_antigen: CD270
ATAR, LIGHTR
Gene name: TNFRSF14, HVEA, HVEM
Out of stock
Ref
00022421
TNFRSF14 / CD270 (N-Terminus) antibody
| ID Covalab | pab73682 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide from the N-terminus part of human TNFRSF14. |
| Activity cross reaction | Reacts with human and mouse TNFRSF14 / CD270. |
| Species | Hu, Ms |
| Labelling | None |
| Form | Antigen affinity purified |
| Preservative | NaN3 0.02% |
| Storage instructions | Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted. |
| Target | TNFRSF14 / CD270 |
| Uniprot ID | Q92956 |
| Gene ID | 8764 |
| Applications | IF, IHC - P, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only: IHC-P (5 µg/ml) WB (1 - 2 µg/ml) |
Write Your Own Review